China Isotope & Radiation Corporation

HKEX:1763.HK

9.59 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 3,894.4062,740.5863,533.972,619.5793,085.8382,057.8562,756.7481,517.4352,333.9251,654.9791,876.2681,373.441,546.4421,125.603668.011590.781590.781590.781538.034538.034538.034538.034
Cost of Revenue 1,897.0081,255.7451,549.081,086.7871,171.152730.638987.919670.277694.847464.73547.231401.81416.608370.651196.815174.691174.691174.691166.234166.234166.234166.234
Gross Profit 1,997.3981,484.8411,984.891,532.7921,914.6861,327.2181,768.829847.1581,639.0781,190.2491,329.037971.631,129.834754.952471.197416.09416.09416.09371.8371.8371.8371.8
Gross Profit Ratio 0.5130.5420.5620.5850.620.6450.6420.5580.7020.7190.7080.7070.7310.6710.7050.7040.7040.7040.6910.6910.6910.691
Reseach & Development Expenses 170.543135.508183.954116.556116.07480.14107.7644.77163.22139.49641.77531.2646.52426.92800000000
General & Administrative Expenses 389.141246.773333.54241.609282.106215.878267.507184.06307.937201.331250.424158.544164.059131.95574.00464.57664.57664.57658.58158.58158.58158.581
Selling & Marketing Expenses 988.903779.465915.231872.8581,040.093780.365960.536482.021,009.225678.276762.439541.493653.591441.093273.671233.476233.476233.476202.688202.688202.688202.688
SG&A 1,436.8181,040.0161,266.611,129.4961,333.521997.6791,249.268668.8041,298.599880.3661,013.66700.873818.456573.638347.675298.052298.052298.052261.268261.268261.268261.268
Other Expenses 0000000000-3.443-1.563-1.563-3.219-3.219-2.228-2.228-2.228-1.4-1.4-1.4-1.4
Operating Expenses 1,428.8951,132.6471,395.3161,219.6021,394.1341,042.0441,343.988677.9061,265.684860.326937.271685.436787.601551.26344.455295.824295.824295.824259.869259.869259.869259.869
Operating Income 422.596327.083567.152307.727480.621262.229425.211155.34353.068316.938324.005277.104322.972189.28890.18188.41188.41188.41184.65784.65784.65784.657
Operating Income Ratio 0.1090.1190.160.1170.1560.1270.1540.1020.1510.1920.1730.2020.2090.1680.1350.150.150.150.1570.1570.1570.157
Total Other Income Expenses Net 149.25123.50741.5644.3543.74916.0796.5839.02943.44920.35280.2111.30129.47416.2349.3139.77639.77639.77636.80236.80236.80236.802
Income Before Tax 571.847350.59608.716312.077524.37278.308431.794164.369396.517337.29404.215288.405352.446205.518139.491128.187128.187128.187121.459121.459121.459121.459
Income Before Tax Ratio 0.1470.1280.1720.1190.170.1350.1570.1080.170.2040.2150.210.2280.1830.2090.2170.2170.2170.2260.2260.2260.226
Income Tax Expense 79.38466.92394.03371.52380.26249.37990.06330.57752.84856.03449.58455.90653.13529.19120.58219.56219.56219.56218.86318.86318.86318.863
Net Income 244.07126.897280.289111.986228.937106.814141.65871.924181.203147.827204.37117.533176.86694.588118.91108.626108.626108.626102.596102.596102.596102.596
Net Income Ratio 0.0630.0460.0790.0430.0740.0520.0510.0470.0780.0890.1090.0860.1140.0840.1780.1840.1840.1840.1910.1910.1910.191
EPS 0.760.40.880.350.720.330.440.220.570.460.640.490.740.420.370.340.340.340.320.320.320.32
EPS Diluted 0.760.40.880.350.720.330.440.220.570.460.640.490.740.420.370.340.340.340.320.320.320.32
EBITDA 528.03444.879644.644412.995542.429359.003484.195233.238403.751366.554361.375309.016355.509222.062107.164104.698104.698104.69898.10498.10498.10498.104
EBITDA Ratio 0.1360.1620.1820.1580.1760.1740.1760.1540.1730.2210.1930.2250.230.1970.160.1770.1770.1770.1820.1820.1820.182